<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01499394</url>
  </required_header>
  <id_info>
    <org_study_id>TCBIO-001-0710</org_study_id>
    <nct_id>NCT01499394</nct_id>
  </id_info>
  <brief_title>Caris Biorepository Research Protocol</brief_title>
  <official_title>The Caris Biorepository Research Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Caris Science, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Caris Science, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Biorepository for Caris Life Sciences is designed for the purpose of making quality&#xD;
      biospecimens and associated clinical data available for research studies related to advancing&#xD;
      precision medicine and improving care for patients.&#xD;
&#xD;
      The Caris Biorepository is a repository of prospectively collected biological specimens and&#xD;
      associated clinical and demographic data gathered from multiple sources to be stored, used&#xD;
      and shared for research. Caris Life Sciences will maintain the data and specimens and will&#xD;
      control access to and use of the information and specimens by multiple individuals for&#xD;
      multiple purposes which may evolve over time.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Caris Biorepository is an effort toward defining the future of medicine incorporating the&#xD;
      discoveries of the genomic era by providing physicians, researchers and scientists access to&#xD;
      quality human specimens and data aimed at improving human health and fighting disease. This&#xD;
      will be accomplished through acquiring and sharing valuable biospecimen information and&#xD;
      clinical outcomes in a collaborative, secure environment. The Caris Biorepository will bridge&#xD;
      the gap and correlate human specimens with clinical and specimen data valuable to multiple&#xD;
      and varying entities interested in advancing science with precision medicine by targeting&#xD;
      disease treatments.&#xD;
&#xD;
      The objective of this project is to develop and implement a state-of-the-science&#xD;
      Biorepository that ensures molecular integrity and clinical relevance of human biospecimens&#xD;
      used in research and clinical medicine. The Caris Biorepository will also provide vital&#xD;
      biospecimens and data to internal researchers and external research collaborators such as&#xD;
      government, academia and industry collaborators for the use of drug development discoveries,&#xD;
      clinically relevant research trials, publications and posters, and the implementation of&#xD;
      future healthcare policies. This project may also impact characterization of trends in&#xD;
      practice patterns and their relation to patient outcomes as well as the economic implications&#xD;
      of differing evaluation, treatment and management paradigms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">November 2025</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Develop biorepository that ensures molecular integrity and clinical relevance of quality human biospecimens and associated clinical data.</measure>
    <time_frame>5 years</time_frame>
    <description>Retention of biospecimen samples with DNA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implement release of specimens from biorepository for testing</measure>
    <time_frame>5 years</time_frame>
    <description>Research for the purposes of cancer laboratory diagnostic tests.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory testing</measure>
    <time_frame>5 years</time_frame>
    <description>DNA and RNA microarray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory testing</measure>
    <time_frame>5 years</time_frame>
    <description>Immunohistochemistry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory testing</measure>
    <time_frame>5 years</time_frame>
    <description>Gene and protein expression, proteomics and matabolomics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory testing</measure>
    <time_frame>5 years</time_frame>
    <description>Mutation analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory testing</measure>
    <time_frame>5 years</time_frame>
    <description>Experiemental lab testing for development of new diagnostic technology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory testing</measure>
    <time_frame>5 years</time_frame>
    <description>Microvesicle discovery, characterization and validation.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>Donor samples reflective of a &quot;normal&quot; non-disease state</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Disease state or condition</arm_group_label>
    <description>Donor samples reflective of a known disease state or condition</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Currently plasma with an opportunity to collect other biospecimens&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers as well as those with a known disease state or condition&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Capacity to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Due to the complexity of state and federal requirements governing the participation of&#xD;
             prisoners in research, prisoners-patients will not be approached for participation in&#xD;
             the Caris Biorepository.&#xD;
&#xD;
          -  Minor subjects will not be included in the Caris Biorepository, as it is possible&#xD;
             biospecimens and data may be stored beyond the time limitations of assent and it may&#xD;
             be impracticable to re-consent these subjects once they become adults.&#xD;
&#xD;
          -  Individuals who lack the capacity to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zoran Gatalica, MD, DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Caris Life Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mary Baker</last_name>
    <email>carisresearch@carisls.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Phoebe Putney Memorial Hospital</name>
      <address>
        <city>Albany</city>
        <state>Georgia</state>
        <zip>31701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Shoemaker, OCN CBCN</last_name>
      <phone>229-312-0354</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Iowa Clinic, PC</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Lepic</last_name>
      <phone>515-875-9815</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eastern Carolina Women's Center</name>
      <address>
        <city>New Bern</city>
        <state>North Carolina</state>
        <zip>28562</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Wynne, BS, CCRC</last_name>
      <phone>252-633-3942</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advantage Clinical Research</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristie Appleton</last_name>
      <email>kristie@nashvillebreastcenter.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Overlake Hospital</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marj Medina, RN CCM BAN</last_name>
      <phone>425-467-3986</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Walla Walla Clinic</name>
      <address>
        <city>Walla Walla</city>
        <state>Washington</state>
        <zip>99362</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauri McKinley</last_name>
      <email>Lauri.McKinley@wallawallaclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CAMC Clinical Trials</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristi Sutphin</last_name>
      <phone>304-388-9945</phone>
      <email>kristi.sutphin@CAMC.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 16, 2011</study_first_submitted>
  <study_first_submitted_qc>December 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 26, 2011</study_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

